A systematic review of the prevalence of DNA damage response gene mutations in prostate cancer

Several ongoing international prostate cancer (PC) clinical trials are exploring therapies that target the DNA damage response (DDR) pathway. This systematic review summarizes the prevalence of DDR mutation carriers in the unselected (general) PC and familial PC populations. A total of 11 electronic...

Descripción completa

Detalles Bibliográficos
Autores principales: Lang, Shona H., Swift, Stephanie L., White, Heath, Misso, Kate, Kleijnen, Jos, Quek, Ruben G.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685596/
https://www.ncbi.nlm.nih.gov/pubmed/31322208
http://dx.doi.org/10.3892/ijo.2019.4842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685596/
https://www.ncbi.nlm.nih.gov/pubmed/31322208
http://dx.doi.org/10.3892/ijo.2019.4842

Ejemplares similares